Latest Topiramate Stories
Studies Demonstrate Favorable Long-Term Safety Profile for Qudexy(TM) XR and Explore its Usefulness for Patients with Swallowing Difficulties WASHINGTON, April 21, 2015 /PRNewswire/ --
DALLAS, March 4, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Epilepsy - Pipeline Review, H1 2015" therapeutic market research report of 330 pages with latest updates,
Free Trial Offer, Co-Pay Program and Prior Authorization Assistance Now Available MAPLE GROVE, Minn., Feb.
CENTER CITY, Minn., Jan. 15, 2015 /PRNewswire-USNewswire/ -- Henry R.
Multiple Presentations Highlight Long-Term Safety, Tolerability, and Efficacy Measures, as Adjunctive Therapy for Patients with Refractory Partial-Onset Seizures SEATTLE, Dec.
Findings Presented at 43rd Annual Meeting of the Child Neurology Society MAPLE GROVE, Minn., Oct.
WOODCLIFF LAKE, N.J., Oct. 20, 2014 /PRNewswire/ -- Eisai Inc. announced today that the U.S.
An Innovative Approach That Puts Clinicians in Charge MAPLE GROVE, Minn., July 28, 2014 /PRNewswire/ -- Upsher-Smith Laboratories,
Authorized Generic Topiramate Extended-Release Capsules Available Nationwide MAPLE GROVE, Minn., July 14, 2014 /PRNewswire/ -- Upsher-Smith
First Branded Product in CNS Portfolio Now Available MAPLE GROVE, Minn., June 30, 2014 /PRNewswire/ -- Upsher-Smith